NDC 60219-2034 – Carbidopa and Levodopa

Carbidopa Hydrate 50 mg/1; Levodopa 200 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug

Product NDC60219-2034

Product details

Brand name
Carbidopa and Levodopa
Generic name
CARBIDOPA and LEVODOPA
Labeler
Amneal Pharmaceuticals NY LLC
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA076521
Marketed since
December 21, 2022
Listing expires
December 31, 2027
Pharmacologic class
Aromatic Amino Acid

Active ingredients

Uses, dosage, side effects and warnings for Carbidopa and Levodopa →

Package NDC codes (3)

Package NDCDescriptionSince
60219-2034-1100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60219-2034-1)Dec 21, 2022
60219-2034-330 TABLET, EXTENDED RELEASE in 1 BOTTLE (60219-2034-3)Dec 21, 2022
60219-2034-5500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60219-2034-5)Dec 21, 2022

Other Carbidopa and Levodopa products